M. Volkonsky

Own Experience of Using Lenvatinib in Patients with Advanced Hepatocellular Carcinoma in Real Clinical Practice based on Moscow City Oncological Hospital №62

A. A. Akopyan, M. Volkonsky, R. Zhikhorev, 2022, Journal of Modern Oncology.

Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice

Yu. V. Vasilyeva, K. Menshikov, A. Sultanbaev, 2022, Russian Journal of Gastroenterology, Hepatology, Coloproctology.

Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation

S. Podvyaznikov, A. Kaprin, A. Mudunov, 2020, Head and Neck Tumors (HNT).

HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?

Y. Andreeva, V. Strelnikov, S. Khokhlova, 2023, International journal of molecular sciences.

The effectiveness and safety of eribulin therapy in HR-positive HER2-negative metastatic breast cancer post-CDK4/6 inhibitor therapy in Russian clinical practice.

E. Zueva, L. Bolotina, A. Vasilevskaya, 2021 .